CGEM
CULLINAN THERAPEUTICS, INC.
Biological Products, (No Diagnostic Substances)- 売上
- $0m
- 時価総額
- $800m
株価 $17.47 · 100株 1,747円
| 期 | 20/12 | 21/12 | 22/12 |
|---|---|---|---|
| 売上 | $0m | $19m | $0m |
| 成長率 | — | — | ▲100.0% |
| 総利益 | — | — | — |
| 総利益率 | — | — | — |
| 販管費 | $17m | $29m | $40m |
| 販管費率 | — | 153.9% | — |
| 営利 | ▲$60m | ▲$68m | $145m |
| 営利率 | — | ▲358.7% | — |
| 純利益 | ▲$52m | ▲$66m | $111m |
| PBR | 4.0 | 1.9 | 1.5 |
| PSR | — | 42.2 | — |
| PGPR | — | — | — |
| PER | — | — | 7 |
| ネットキャッシュ | $168m | $60m | $156m |
| EV/EBITDA | — | — | 4.4 |
| Rule of 40 | — | — | — |
| セールス効率 | — | — | — |
※Rule of 40は売上成長率+営業利益率、セールス効率は売上総利益増加÷販管費増加(販管費増のときのみ)
